ENTITY

Aptamer Group (APTA LN)

12
Analysis
Health Care • United Kingdom
Aptamer Group Plc is a biotechnology company that provides Optimer binders for use in research, diagnostics, and therapeutics. The company utilizes its proprietary Optimer technology to offer custom development services for oligonucleotide-based binders, aiming to deliver transformational solutions across the life sciences industry. Aptamer Group was founded in 2008 and is headquartered in York, United Kingdom.
more
bullish•Aptamer Group
•06 Aug 2026 22:42

Primer: Aptamer Group (APTA LN) - Aug 2026

Proprietary Optimer® platform offers a potential technological edge over traditional antibody-based solutions, with applications across...

Share
bullish•Aptamer Group
•15 Jul 2026 20:42•Issuer-paid

Hybridan Small Cap Feast: 8 July 2026

The developer of synthetic binders for the life sciences industry announces that it has commenced development of Optimer binders for a potential...

Logo
Hybridan
121 Views
Share
bullish•Aptamer Group
•19 Feb 2026 10:36•Issuer-paid

Hybridan Small Cap Feast: 11 February 2026

These are being used as an enabling technology for stability at room temperature, the specialised TrueAmp polymerase maximises coverage across...

Logo
Hybridan
158 Views
Share
bullish•Cross Asset Strategy
•11 Mar 2025 10:02•Issuer-paid

PISCES – Shooting the Lights Out or Shooting Ourselves in the Foot?

It will kick off with a five-year stint in the “FCA sandbox” which allows the Government to modify the platform or disapply certain parts of the...

Logo
Hybridan
313 Views
Share
bullish•Acuity RM Group
•20 Jul 2026 21:51•Issuer-paid

Hybridan Small Cap Feast: 13 July 2026

The software group specialising in the cybersecurity sector of the Governance, Risk and Compliance market announces the first sale of its new...

Logo
Hybridan
114 Views
Share
x